KR EN
Daewoong
Global Healthcare Group
The Best Partner for You

Global Network

Daewoong Pharmaceutical is becoming a global healthcare group

GLOBAL 2025
VISION

Daewoong Pharmaceutical currently has the most overseas corporations (13) and branches (3) among domestic pharmaceutical companies, and has constructed various collaboration infrastructure including research, development, manufacturing, sales, etc. with clients to supply products desired by local markets to strengthen its local competitiveness.

Furthermore, we will ceaselessly search for, hire and foster outstanding human resources from around the world and help them contribute to the development of local pharmaceutical industries to provide the foundation for them to grow into global healthcare companies.

Global 2025 vision
  • Localization strategy
    We will continuously pursue business structure and infrastructure innovation to become a company that researches, develops and distributes products desired by the market through the collaboration of local customers and employees, while contributing to the development of the local industry.
  • Strengthening market competitiveness
    We will expand the self-management infrastructure of overseas corporation in order to procure business sustainability, while constructing a collaborative network with multiple partners such as local manufacturers, research centers and pharmaceutical companies, while the HQ directly manages core clients to continuously expand its market dominance.
  • Fostering global talents
    We will ceaselessly find and support outstanding talents with the will and passion for global collaboration including domestic and foreign medical scientists, researchers and international students, and actively recruit human resources who wish to grow continuously with the company and help cultivate them to empower them to develop the global pharmaceutical industry.

Global Presence

  • Branch Operations
    in Asia & US     8
  • R&D Centers
    Worldwide     4
  • Partners
    Worldwide     100+

Network

Boston, Massachusetts, USA

Daewoong Innovation Holdings(DIH) Daewoong Innovation Holdings, Inc.
Office Address 1 Broadway, 14th Floor, Cambridge, MA 02142 TEL +1 857-207-9051
Daewoong Innovation Holdings (DIH) is one of the subsidiaries of Daewoong Pharmaceutical, and was established in May 2021.
DIH is located in Boston, Massachusetts as the World's largest biocluster, for global open collaboration, and Top Universities such as Harvard and MIT are located as well as many multinational pharmaceutical companies use Boston as their base.
DIH will create a network with international scholars/researchers, pharmaceutical/bio experts, and investors.
Furthermore DIH plans to build up collaborations with global partners using various business models including strategic partnerships, licensing-in, or joint development of new technologies.
DIH's mission is to expand the presence in USA, absorbing the latest R&D trends, and developing new drugs for unmet needs of patients through collaborating with biotechs and university-industry partners in USA.
Daewoong Pharmaceutical will utilize DIH to contribute to the growth of Korean and global pharmaceutical market by expanding global open collaboration.